 |
 Play Video: The Importance of Insider Buying
|
|
|
| Date | Insider | Price | Amount |
|---|
11-9-2023
Insider Buy |
Capital Global Healthcare Fund (master), LP Decheng
>10% Owner |
$12.50
CAGR »
|
$4,687,500.00
375,000 shares |
11-9-2023
Insider Buy |
Xiangmin Cui
Director and >10% Owner |
$12.50
CAGR »
|
$4,687,500.00
375,000 shares |
9-23-2021
Insider Buy |
Robert E. Conway
Director |
$10.08
CAGR »
|
$151,153.50
15,000 shares |
9-23-2021
Insider Buy |
Christopher Peetz
Director |
$10.17
CAGR »
|
$19,323.00
1,900 shares |
9-17-2021
Insider Buy |
Peter A. Thompson
Director and >10% Owner |
$9.40
CAGR »
|
$9,499,987.80
1,010,637 shares |
9-17-2021
Insider Buy |
Decheng Capital China Life Sciences USD Fund III, L.P.
>10% Owner |
$9.40
CAGR »
|
$14,499,998.20
1,542,553 shares |
9-17-2021
Insider Buy |
ORBIMED ADVISORS LLC
Director and >10% Owner |
$9.40
CAGR »
|
$9,499,987.80
1,010,637 shares |
9-17-2021
Insider Buy |
Xiangmin Cui
Director and >10% Owner |
$9.40
CAGR »
|
$14,499,998.20
1,542,553 shares |
5-30-2019
Insider Buy |
James Paul Rickey
Senior VP and CFO |
$4.95
CAGR »
|
$49,500.00
10,000 shares |
1-18-2019
Insider Buy |
ORBIMED ADVISORS LLC
Director and >10% Owner |
$5.37
CAGR »
|
$1,999,997.43
372,439 shares |
1-18-2019
Insider Buy |
Peter A. Thompson
Director and >10% Owner |
$5.37
CAGR »
|
$1,999,997.43
372,439 shares |
1-18-2019
Insider Buy |
Alpine ImmunoSciences, L.P.
>10% Owner |
$5.37
CAGR »
|
$1,024,998.75
190,875 shares |
1-18-2019
Insider Buy |
Jay Venkatesan
Director and >10% Owner |
$5.37
CAGR »
|
$1,024,998.75
190,875 shares |
1-18-2019
Insider Buy |
Mitchell Gold
Executive Chairman and CEO |
$5.37
CAGR »
|
$1,024,998.75
190,875 shares |
1-18-2019
Insider Buy |
James N. Topper
Director and >10% Owner |
$5.37
CAGR »
|
$1,999,997.43
372,439 shares |
1-18-2019
Insider Buy |
Frazier Life Sciences VIII, L.P.
>10% Owner |
$5.37
CAGR »
|
$1,999,997.43
372,439 shares |
Also See: Institutional Holders of ALPN
Also See: SEC filings
Below we present the annualized performance delivered by ALPN stock since 11-9-2023 (the date of the most recent
insider purchase). The performance of the investment from the time ALPN insider buying occurred is the ultimate
test of whether insiders were right about ALPN being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
11/10/2023 |
|
| End date: |
04/19/2024 |
|
| Start price/share: |
$12.22 |
|
| End price/share: |
$64.55 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
428.23% |
|
| Annualized Gain: |
976.91% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$52,823.00 |
|
| Years: |
0.44 |
|
ALPN Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent ALPN insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding ALPN
|
|
Free ALPN Email Alerts:
